Analysts think ARTL stock price could increase by 445%
May 09, 2025, 11:25 AM
6.80%
What does ARTL do
Artelo Biosciences, a clinical-stage biopharmaceutical company based in Solana Beach, California, focuses on developing therapeutics targeting lipid-signaling pathways and the endocannabinoid system. Its key programs include ART27.13 for anorexia and ART26.12 for cancer, pain, and anxiety.
4 analysts think ARTL stock price will increase by 444.66%. The current median analyst target is $5.61 compared to a current stock price of $1.03. The lowest analysts target is $5.05 and the highest analyst target is $6.30.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
